Atlantic Therapeutics Ltd.

LOS ANGELES--(BUSINESS WIRE)--Caldera Medical, a leader in women’s health solutions, is proud to announce the appointment of John Pitstick as its new Chief Financial Officer & EVP Corporate Development. With a strategic focus on advancing Caldera Medical's position in the women’s health sector, Caldera Medical completed its acquisition of Atlantic Therapeutics based in Galway Ireland on September 1st of this year and maintains an innovation and operations team in Ireland as its European headquarters. John's appointment aligns with the company's accelerated growth and ambitious plans for future acquisitions. John Pitstick – A Synthesis of Expertise and Vision John Pitstick began his career with Ernst & Young managing a global client base and contributing to several IPOs. His distinguished career as a CFO is marked by significant achievements in growing both private and publicly traded technology and healthcare companies. John’s financial acumen and strategic insight is underscored by his role as a member of the board of directors of a publicly traded financial services company, where he also serves as chairman of the audit committee. Driving Growth through Strategic Acquisitions As CFO, John's expertise in leading Mergers and Acquisitions (M&A) will be pivotal. His experience in overseeing transactions exceeding $3 billion, coupled with his success in raising over $1 billion in financing, equips him to guide Caldera Medical through its ambitious expansion plans, including strategic acquisitions that will enhance the company’s portfolio and market presence. About Caldera Medical Caldera Medical is a medical device company solely focused on women’s health, committed to improving the quality of life for women. Caldera Medical develops, manufactures, and markets surgical products for treating Stress Urinary Incontinence, Pelvic Organ Prolapse, Polyps, and Fibroids. Known for its customer intimacy principle and significant humanitarian program, Caldera Medical is dedicated to treating one million women in underserved populations globally by 2025. Connect with Caldera Medical For more about Caldera Medical’s growth strategy and John Pitstick’s role, visit , LinkedIn, Twitter.

Caldera Medical , a women’s health medical device company, today announced the completion of its acquisition of Atlantic Therapeutics, a provider of non-invasive pelvic floor strengthening and nerve stimulation solutions for women. Caldera solely focuses on medical devices for women’s health, manufacturing and marketing surgical products for the treatment of stress urinary incontinence, pelvic organ prolapse polyps, and fibroids. Atlantic, which is based in Ireland, specializes in the development of medical devices, related software, and connected health technologies primarily to treat incontinence, and sexual health dysfunctions. Caldera’s portfolio includes its Desara family of surgical products to treat stress urinary incontinence, the Vertessa Lite polypropylene mesh for the treatment of pelvic organ prolapse, and the Benesta system for in-office polyp removal. Through the acquisition, Caldera adds Atlantic’s FDA-cleared Innovo device to its existing portfolio. The Innovo device is a urinary incontinence treatment option for at-home use where the user puts on the Innovo multipath shorts which contain electrical muscle stimulation technology connected to a remote-like controller. Through a 30-minute session, Innovo completes 180 pelvic floor contractions, helping to re-educate the muscles and make them stronger. Those stronger muscles have more control over the bladder. The device is currently priced at €399 for the starter kit , which includes the multipath shorts, prep spray, and controller. "We are thrilled to acquire Atlantic Therapeutics and scale the rapidly growing Innovo products worldwide," said Bryon Merade, CEO of Caldera, in a press release announcing the acquisition completion. "This acquisition aligns perfectly with our mission and allows us to offer an even more comprehensive suite of solutions to healthcare providers and patients alike." Caldera will maintain a European headquarters and innovation center in Galway, Ireland.

LOS ANGELES--(BUSINESS WIRE)-- Caldera Medical, a women’s health medical device company that develops and markets best-in-class products for the treatment of Stress Urinary Incontinence, Pelvic Organ Prolapse, Polyps and Fibroids, announced today that it has completed its acquisition of Atlantic Therapeutics, an Ireland based provider of non-invasive pelvic floor strengthening and nerve stimulating solutions for women. The acquisition bolsters Caldera Medical’s expanding portfolio, furthering its mission to improve the quality of life for women! By acquiring Atlantic Therapeutics, Caldera Medical adds the commercial leading non-invasive, FDA cleared, Innovo product family as a first-line therapy for women with stress urinary incontinence. Caldera Medical will maintain a European headquarters and innovation center in Galway, Ireland. "We are thrilled to acquire Atlantic Therapeutics and scale the rapidly growing Innovo products worldwide," said Bryon Merade, CEO of Caldera Medical, "This acquisition aligns perfectly with our mission and allows us to offer an even more comprehensive suite of solutions to healthcare providers and patients alike." “Since its formation, the team at Atlantic Therapeutics has demonstrated the huge potential of Innovo,” commented Susan Trent, CEO of Atlantic Therapeutics, “This unique technology with robust clinical data is ideally placed to serve the millions of women worldwide who suffer the daily distress of SUI. Caldera Medical’s ability to maximize this potential is the perfect next step. I am delighted that we will see Innovo thrive within Caldera Medical and want to thank Bryon and the team for their dedication to women’s health.” About Caldera Medical Caldera Medical is a medical device company solely focused on women’s health with a commitment to our mission of “Improving the Quality of Life for Women!” Caldera Medical develops, manufactures and markets best-in-class surgical products for the treatment of Stress Urinary Incontinence, Pelvic Organ Prolapse Polyps and Fibroids. Caldera Medical forms close relationships with surgeons and continues to build the company around a principle of customer intimacy. In partnership with its surgeon customers, Caldera Medical has the largest humanitarian program of any women’s health company. It is committed to treating one million women in underserved populations around the world by the year 2027. About Atlantic Therapeutics Atlantic Therapeutics, based in Ireland, specializes in the development of medical devices, related software, and connected health technologies. The company primarily treats incontinence, sexual health dysfunctions, and other related disorders. They produce pelvic floor strengthening devices and nerve stimulation products, all of which are supported by robust clinical evidence and have undergone randomized controlled trials. Healthcare professionals worldwide depend on Atlantic Therapeutics' solutions to enhance the lives of tens of thousands of patients annually.